Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Research

19-NEU-3925-stereotactic-radiosurgery-brain-mets-650×450
September 16, 2019/Cancer

High-Dose Neoadjuvant Radiosurgery for Brain Metastases Appears Safe, Effective in Early Results from Phase 1/2 Study

Dose-escalation trial shows local control with low toxicity, low leptomeningeal recurrence

Figure7
September 10, 2019/Neurosciences/Research

Augmented Reality System for Evaluating Post-mTBI Combat Readiness Promises Clinical Payoffs Too

DoD grant supports creation, validation of multidimensional field assessments

19-NEU-3934-glioblastoma-ADAMDEC1-450×650

Novel Pathway Critical to Glioma Stem Cells Identified as Therapeutic Target in Glioblastoma

Newly discovered signaling loop is shown to be druggable

18-NEU-5689 Alzheimers-brain-650×450
August 22, 2019/Geriatrics

Lenalidomide for Early Alzheimer’s: Taking on Multiple Neuropathologies at Once

New clinical trials size up an immunomodulator’s pleiotropic effects

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-NEU-3900-immunotherapy-650×450
August 20, 2019/Cancer

Immunotherapy for Non-Small Cell Lung Cancer Brain Metastases: Ready for Prime Time

Companion studies reveal efficacy indicators for PD-1/PD-L1 inhibition

Epilepsy testing

Integrated Studies Focus in on Optimal Prediction of Epilepsy Treatment Response

Grant enables pooling of genomics, molecular medicine, animal models, advanced neuroimaging

19-NEU-3855-Exoskeleton-650×450
July 31, 2019/Neurosciences/Research

Piloting a Powered Exoskeleton for Gait Training in Multiple Sclerosis

New study aims to assess a potential new indication for the technology

19-NEU-4042-social-buzz-650×450

Can Social Media Buzz Increase Your Academic Citations?

Study looks for correlations in neurology research

19-NEU-318 T-cell-activation-650×450

Grant Boosts Efforts to Take on Glioblastoma by Targeting Immunosuppressive Cells

Focus is on inhibiting action of myeloid-derived suppressor cells

Self-portrait
July 15, 2019/Neurosciences/Research

Tardive Dyskinesia Therapy Holds Up Over Long-Term Assessment

Extension study of VMAT2 inhibitor helps confirm a new therapeutic era

BackPage 8 of 17Next

Advertisement

Ad